有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(1R)-1-(2-chlorophenyl)ethyl]-2-(4-fluorophenyl)sulfanylacetamide | —— | C16H15ClFNOS |
|
—— | 1-[1-[(4-Fluorophenyl)methyl]-2,5-dimethylpyrrol-3-yl]-2-(4-fluorophenyl)sulfanylethanone | —— | C21H19F2NOS |
|
—— | (2R)-2-(4-fluorophenyl)sulfanyl-N-(furan-2-ylmethyl)propanamide | —— | C14H14FNO2S |
|
—— | methyl 5-[(2R)-2-(4-fluorophenyl)sulfanylpropanoyl]-2,4-dimethyl-1H-pyrrole-3-carboxylate | —— | C17H18FNO3S |
|
—— | N-[4-(2,5-dimethylphenyl)sulfanylphenyl]-2-(4-fluorophenyl)sulfanylacetamide | —— | C22H20FNOS2 |
|
—— | [2-[[(1R)-1-(3-chlorophenyl)ethyl]amino]-2-oxoethyl] 2-(2-methylphenyl)sulfanylacetate | —— | C19H20ClNO3S |
|
—— | N,N-dimethyl-4-[(2S,5R)-5-[(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-1,3-oxazolidin-3-ium-2-yl]aniline | —— | C19H22N5OS2+ |
|
—— | (2R,3R,4R,5R)-1,1-bis(ethylsulfanyl)hexane-2,3,4,5-tetrol | —— | C10H22O4S2 |
|
—— | [2-(4-Methylanilino)-1,3-thiazol-4-yl]methyl 2-(2,4-dimethylphenyl)sulfanylacetate | —— | C21H22N2O2S2 |
|
—— | 6-[(3R)-3-[1-(2-methoxyethyl)imidazol-2-yl]piperidin-1-yl]-2-methylsulfanylpyrimidin-4-amine | —— | C16H24N6OS |
|
—— | 6-[(3S)-3-[1-(2-methoxyethyl)imidazol-2-yl]piperidin-1-yl]-2-methylsulfanylpyrimidin-4-amine | —— | C16H24N6OS |
|
—— | (4S)-4-(bromomethyl)-11-cyclohexyl-5-thia-2,7,13-triaza-11-azoniatricyclo[7.4.0.02,6]trideca-1(9),6-dien-8-one | —— | C15H22BrN4OS+ |
|
—— | 4-(4-Methyl-5-methylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-ium | —— | C9H17N4S+ |
|
—— | 2-[(5-ethyl-1H-1,2,4-triazol-3-yl)sulfanyl]-1-[(2R)-2-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl]ethanone | —— | C15H22N6O2S |
|
—— | 2-[(5-ethyl-1H-1,2,4-triazol-3-yl)sulfanyl]-1-[(2S)-2-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-1-yl]ethanone | —— | C15H22N6O2S |
|
—— | 3-((4-Bromobenzyl)thio)-6-(pyridin-4-yl)pyridazine | —— | C16H12BrN3S |
|
—— | 3-((3-Chlorobenzyl)thio)-6-(pyridin-4-yl)pyridazine | —— | C16H12ClN3S |
|
—— | 2-methyl-5-[3-[4-[(3R)-oxolan-3-yl]triazol-1-yl]propylsulfanyl]-1,3,4-thiadiazole | —— | C12H17N5OS2 |
|
—— | 2-methyl-5-[3-[4-[(3S)-oxolan-3-yl]triazol-1-yl]propylsulfanyl]-1,3,4-thiadiazole | —— | C12H17N5OS2 |
|
—— | (3S)-3-(5-benzylsulfanyl-4-methyl-1,2,4-triazol-3-yl)-1-(furan-2-ylmethyl)piperidine | —— | C20H24N4OS |
|
—— | [amino-(4-ethylanilino)methylidene]-[6-oxo-4-(pyridin-2-ylsulfanylmethyl)-1H-pyrimidin-2-yl]azanium | —— | C19H21N6OS+ |
|
—— | (2R)-N-cyclohexyl-2-[(6-methyl-5-oxo-4H-1,2,4-triazin-3-yl)sulfanyl]propanamide | —— | C13H20N4O2S |
|
—— | (2R)-2-(4-methylpyrimidin-2-yl)sulfanylpropanoate | —— | C8H9N2O2S- |
|
—— | (2S)-2-[(5-benzyl-4-methyl-6-oxo-1H-pyrimidin-2-yl)sulfanyl]butanoate | —— | C16H17N2O3S- |
|
—— | Ethyl 2-[1,4-dimethyl-5-[(2-methylphenyl)methyl]-6-oxopyrimidin-2-yl]sulfanylacetate | —— | C18H22N2O3S |
|
—— | 4-ethyl-3-methyl-5-[2-[4-[(3S)-oxolan-3-yl]triazol-1-yl]ethylsulfanyl]-1,2,4-triazole | —— | C13H20N6OS |
|
—— | 4-ethyl-3-methyl-5-[2-[4-[(3R)-oxolan-3-yl]triazol-1-yl]ethylsulfanyl]-1,2,4-triazole | —— | C13H20N6OS |
|
—— | 2-[[4-methyl-5-(2-methylfuran-3-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C15H20N4O3S |
|
—— | 2-[4-Chloro-6-(dipropylamino)pyrimidin-2-yl]sulfanyl-1-(4-ethylpiperazin-4-ium-1-yl)ethanone | —— | C18H31ClN5OS+ |
|
—— | 2-((2-Chloro-6-fluorobenzyl)thio)-4,6-dimethylnicotinonitrile | —— | C15H12ClFN2S |
|
—— | 2-[(6-oxo-1H-pyrimidin-2-yl)sulfanyl]-N-[(1R)-1-phenylethyl]acetamide | —— | C14H15N3O2S |
|
—— | 4-propyl-2-[(2,4,5-trimethylphenyl)methylsulfanyl]-1H-pyrimidin-6-one | —— | C17H22N2OS |
|
—— | (2R)-2-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(methylcarbamoyl)propanamide | —— | C13H13BrN4O3S |
|
—— | 2-[[5-(4-bromophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-cyclopropylacetamide | —— | C13H12BrN3O2S |
|
—— | [2-Oxo-2-(2-phenylsulfanylanilino)ethyl] 1-benzofuran-2-carboxylate | —— | C23H17NO4S |
|
—— | N-(1-adamantyl)-2-[3-cyano-6-methyl-4-(trifluoromethyl)pyridin-2-yl]sulfanylacetamide | —— | C20H22F3N3OS |
|
—— | 3-((2-Chloro-6-fluorobenzyl)thio)-6-(furan-2-yl)pyridazine | —— | C15H10ClFN2OS |
|
—— | 2-[(2,4-Difluorophenyl)methylsulfanyl]-6-ethyl-3-methyl-5-[(3-methylphenyl)methyl]pyrimidin-4-one | —— | C22H22F2N2OS |
|
—— | 3-[(4-Chlorophenyl)methylthio]-6-(2-furanyl)pyridazine | 872701-27-4 | C15H11ClN2OS |
|
—— | 2-((6-(furan-2-yl)pyridazin-3-yl)thio)-N-(4-methylbenzyl)acetamide | —— | C18H17N3O2S |
|
—— | N-tert-butyl-2-(7-butyl-1,3-dimethyl-2,4-dioxopyrimido[4,5-d]pyrimidin-5-yl)sulfanylacetamide | —— | C18H27N5O3S |
|
—— | 2-{[6,8-Dimethyl-2-(2-methylpropyl)-5,7-dioxo-5H,6H,7H,8H-[1,3]diazino[4,5-D]pyrimidin-4-YL]sulfanyl}-N-[(furan-2-YL)methyl]acetamide | —— | C19H23N5O4S |
|
—— | (2R)-2-(7-butyl-1,3-dimethyl-2,4-dioxopyrimido[4,5-d]pyrimidin-5-yl)sulfanyl-N,N-dimethyl-3-oxobutanamide | —— | C18H25N5O4S |
|
—— | 2-[(2S)-butan-2-yl]sulfanyl-4-(4-chlorophenyl)thiophene-3-carbonitrile | —— | C15H14ClNS2 |
|
—— | 5-[(1R)-1-(4,6-dimethylpyrimidin-2-yl)sulfanylethyl]-3-pyridazin-3-yl-1,2,4-oxadiazole | —— | C14H14N6OS |
|
—— | 5-[(1S)-1-(4,6-dimethylpyrimidin-2-yl)sulfanylethyl]-3-pyridazin-3-yl-1,2,4-oxadiazole | —— | C14H14N6OS |
|
—— | 2-(4-acetamidophenoxy)-N-(2-phenylsulfanylphenyl)acetamide | —— | C22H20N2O3S |
|
—— | 7-{[(2-Fluorophenyl)methyl]sulfanyl}-3-methyl-4H-[1,3,4]thiadiazolo[2,3-C][1,2,4]triazin-4-one | —— | C12H9FN4OS2 |
|
—— | Ethyl 4-({3-methyl-4-oxo-4H-[1,3,4]thiadiazolo[2,3-C][1,2,4]triazin-7-YL}sulfanyl)-3-oxobutanoate | —— | C11H12N4O4S2 |
|
—— | 7-[(2-Chloro-6-fluorophenyl)methylsulfanyl]-3-methyl-[1,3,4]thiadiazolo[2,3-c][1,2,4]triazin-4-one | —— | C12H8ClFN4OS2 |
|